NCT07634848

Ivarmacitinib for Refractory Behcet's Syndrome

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2026-06-01Est. Completion: 2027-05-31

Enrollment target: 30 participants

Locations

Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, Beijing Municipality, China

Contact

Behcet Syndrome

Behçet's disease (BD) is a multi-system auto inflammatory disorder with vasculitic features. The exact etiological of B…

Asyut, EgyptCompleted Feb 1, 2025

Behcet Syndrome

Behçet's disease (BD) is a systemic vasculitis affecting both small and large blood vessels in the venous and arterial s…

Asyut, EgyptCompleted Jan 1, 2025

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.